We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A leadless pacing-defibrillator system was safe and met ...

GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded ...

Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive ...

The FDA approved Medtronic’s defibrillator that tailors cardiac resynchronization therapy (CRT) to each patient by using an algorithm to adjust pacing. With its ability to confirm if pulses are ...

Yet the evidence should not be overinterpreted, as conventional pacing maintains an important role, says Elena Arbelo.

Criteria to identify appropriate candidates for CRT and CRT-D are based on the experiences gained during clinical trials ( Table II). Trials to date have predominantly included patients with normal ...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. (“AtaCor”) announced today that it will present initial findings from its first-in-human extravascular implantable cardioverter ...

The Concerto study was an international, multicenter, prospective, non-randomized clinical trial. Our primary objectives were measurement of the efficacy of atrial cardioversion in this CRT population ...

NEW ORLEANS -- An investigational extravascular implantable cardioverter-defibrillator (ICD) continues to demonstrate it can appropriately shock patients and prevent sudden cardiac death, extended ...

Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc (MDT), a ...